glp 1 for addiction treatment GLP-1 Agonists: Expanding Horizons in How Can GLP-1 Agonists Be

Description

Mechanism of Action Pancreas: Increases glucose-dependent insulin secretion, decreases glucagon Brain: Enhances satiety Stomach: Slows gastric emptying Main Indications Type 2 diabetes mellitus Obesity/weight management Cardiovascular risk reduction Common Drugs Exenatide Liraglutide Semaglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 agonist) Key Benefits Significant weight loss Low hypoglycemia risk Cardiovascular protection Major Side Effects Nausea/vomiting (most common) Pancreatitis (rare) Thyroid C-cell tumors (boxed warning) Contraindications Multiple Endocrine Neoplasia type 2 (MEN2) Personal/family history of medullary thyroid carcinoma #Pharmaceuticals #GLP1 #Diabetes #Obesity #Healthcare #Biotech #ClinicalResearch #Endocrinology #MedicalAffairs To view or add a comment, sign in More Relevant Posts New Experimental Study | Diabetes & Lipid Management Can Cinnamomum zeylanicum (Ceylon cinnamon) enhance conventional therapy in diabetes

GLP-1 Causes Muscle Loss: A Scientific Review Medical professionals are concerned about the muscle loss associated with weight loss during GLP-1 medication use, sharing their review of 18 randomized controlled trials in the journal Current Diabetes Reviews